Skip to Content
Merck

Glutamine Metabolism Controls Chondrocyte Identity and Function.

Developmental cell (2020-05-30)
Steve Stegen, Gianmarco Rinaldi, Shauni Loopmans, Ingrid Stockmans, Karen Moermans, Bernard Thienpont, Sarah-Maria Fendt, Peter Carmeliet, Geert Carmeliet
ABSTRACT

Correct functioning of chondrocytes is crucial for long bone growth and fracture repair. These cells are highly anabolic but survive and function in an avascular environment, implying specific metabolic requirements that are, however, poorly characterized. Here, we show that chondrocyte identity and function are closely linked with glutamine metabolism in a feedforward process. The master chondrogenic transcription factor SOX9 stimulates glutamine metabolism by increasing glutamine consumption and levels of glutaminase 1 (GLS1), a rate-controlling enzyme in this pathway. Consecutively, GLS1 action is critical for chondrocyte properties and function via a tripartite mechanism. First, glutamine controls chondrogenic gene expression epigenetically through glutamate dehydrogenase-dependent acetyl-CoA synthesis, necessary for histone acetylation. Second, transaminase-mediated aspartate synthesis supports chondrocyte proliferation and matrix synthesis. Third, glutamine-derived glutathione synthesis avoids harmful reactive oxygen species accumulation and allows chondrocyte survival in the avascular growth plate. Collectively, our study identifies glutamine as a metabolic regulator of cartilage fitness during bone development.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Collagen Type II Antibody, clone 6B3, clone 6B3, Chemicon®, from mouse
Sigma-Aldrich
Monoclonal Anti-β-Actin antibody produced in mouse, clone AC-15, ascites fluid